2015
DOI: 10.1200/jco.2015.33.15_suppl.e12560
|View full text |Cite
|
Sign up to set email alerts
|

Integrated analysis of miRNAs expression in breast cancer patients to detect genes deregulation involved in malignant transformation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…TGFBR3 inhibits breast cancer progression through TGF-beta signaling (Lee et al, 2010). In addition, other molecules in module 1 such as ADAMTS5 (Fontanil et al, 2017), ARHGAP20 (Asaduzzaman et al, 2017), C2orf88 (Lo et al, 2015), EZH1 (Liu et al, 2012), FAM13A (Goto-Yamaguchi et al, 2018), FGF1 (Slattery et al, 2013), GNAL (Yi et al, 2009), GRAMD3 (Boiles et al, 2015), PELI2 (Zang et al, 2017), PLSCR4 (Sahay et al, 2015), PTPN14 (Belle et al, 2015), RBMS3 (Zhu et al, 2019a), SH3BGRL2 (Alexe et al, 2007;Wen et al, 2018), let-7c (Fu et al, 2017), mir-100 (Jiang et al, 2016b), mir-10b (Wang et al, 2016b), mir-125b (Wang et al, 2019a), mir-139 (Dai et al, 2017), and mir-21 (Yan et al, 2008;Yanwirasti and Arisanty, 2017;Zhu et al, 2019b) have been reported to play important roles in breast cancer. Module 2 had nine nodes, including two miRNAs, five lncRNAs, and two protein-coding genes.…”
Section: Modules In the Dysregulated Network Relate To The Survival Omentioning
confidence: 99%
“…TGFBR3 inhibits breast cancer progression through TGF-beta signaling (Lee et al, 2010). In addition, other molecules in module 1 such as ADAMTS5 (Fontanil et al, 2017), ARHGAP20 (Asaduzzaman et al, 2017), C2orf88 (Lo et al, 2015), EZH1 (Liu et al, 2012), FAM13A (Goto-Yamaguchi et al, 2018), FGF1 (Slattery et al, 2013), GNAL (Yi et al, 2009), GRAMD3 (Boiles et al, 2015), PELI2 (Zang et al, 2017), PLSCR4 (Sahay et al, 2015), PTPN14 (Belle et al, 2015), RBMS3 (Zhu et al, 2019a), SH3BGRL2 (Alexe et al, 2007;Wen et al, 2018), let-7c (Fu et al, 2017), mir-100 (Jiang et al, 2016b), mir-10b (Wang et al, 2016b), mir-125b (Wang et al, 2019a), mir-139 (Dai et al, 2017), and mir-21 (Yan et al, 2008;Yanwirasti and Arisanty, 2017;Zhu et al, 2019b) have been reported to play important roles in breast cancer. Module 2 had nine nodes, including two miRNAs, five lncRNAs, and two protein-coding genes.…”
Section: Modules In the Dysregulated Network Relate To The Survival Omentioning
confidence: 99%
“…From Fig 6A, it can be seen that the target gene set related to hsa-mir-371a was significantly enriched in several terms closely related to breast cancer, including Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer, pathways in cancer, mitotic cell cycle process, and Signaling by Rho GTPases. For example, Transcriptional activity of SMAD2/ SMAD3:SMAD4 heterotrimer involved in the degradation of SKI/SKIL, thus causing malignant transformation in breast cancer [57]. The deregulation of cell cycle is a hallmark of cancer including breast cancer, which allows for limitless cell division [58,59].…”
Section: Case Studiesmentioning
confidence: 99%